📢 El Dr Josep Samitier ha participado hoy en el #NanoRare Disease Day, resaltando el papel que tiene la #nanomedicina en el #PlanComplementario de #Biotecnología aplicada la #Salud para el diagnostico y tratamiento de las #enfermedadesraras .
#NanoMedSpain #raredisease
n-Lorem Foundation poster at ASHG on #antisense oligonucleotide therapy for #nanorare disease. Focus on pacs1foundation as examples of treatable mutations!
📣 Comença la jornada NanoRare Diseases Day amb #NanomedSpain sobre com la nanomedicina pot impulsar la recerca en #malaltiesrares
Join Stanley Crooke, M.D., Ph.D., Founder & CEO of n-Lorem Foundation, a #nonprofit that develops treatments for #nanorare patients.
He discusses the challenges behind developing a new modality for these patients and his vision for the company’s long-term sustainability.
ow.ly/zTwW50L6kQQ
Interested in learning more about KIF1A-Associated Neurological Disorder (KAND)?
Read Revealing Rare Gene's new blog post here: genome.bio/post/personali…
#ultrarare #nanorare #raredisease #KIF1A #KAND #RareisOne #biotechblog #lajollalabs #RevealingRareGenes
A fantastic start to our DPhil Day! 👏 Prof. Laurent Servais opened with a presentation entitled:
Trials in rare, very rare, ultrarare and nanorare diseases: how can we manage to demonstrate efficacy on very small numbers?
Next up, presentations from our Medical Sciences students!
ICYMI: Tracy Cole, Ph.D., n-Lorem's Sr. Director of Research, speaks about the n-of-1 journey at the Illumina Genomics Forum. #CareAboutRare #RareDisease #RareCommunity #nlorem #nanorare
Target ALS is committed to finding treatments for all forms of ALS.
We are proud of our collaboration with n-Lorem Foundation Foundation to find treatments for nano-rare forms of ALS.
#collaboration #nlorem #nanorare #EndALS #ALSresearch
👥 Iniciem la 4rta edició del #NanoRare Disease Day amb la plataforma #NanoMedSpain , IBEC i Hospital Sant Joan de Déu Barcelona CAT
🔗 Podeu seguir-nos online nanomedspain.net/nrdd2023/
Curing #OrphanDiseases will pave the path for #PrecisionMedicine for #CommonDisorders . All human diseases are #genetic . Let’s start with the #NanoRare conditions. #CureRareDisease #CureKCNC1 #GeneChat
Tomorrow, n-Lorem’s Senior Director of Research, Tracy Cole, Ph.D., provides expertise in n-of-1 therapies, ASO technology and many other precision medicine topics in two panels at the inaugural Illumina Genomics forum. #CareAboutRare #RareDisease #RareCommunity #nlorem #nanorare
Only 1.2% of ~1 million people know they are at risk for cancers. Let that sink in. Awareness, genetic testing, aggressive monitoring can save lives!
#wematter #cmmrd #nanorare #rarediseasetruth #notsorare #lynchsyndrome #curepediatriccancer #morethan4 Dana-Farber/Boston Children's
Advocating 24x7
Today we got to meet Garrett from Senator Thom Tillis office. We called on their office to make funding for NIH a national priority.
#wematter #rarediseasetruth #cmmrd #research #nanorare
Rally for Medical Research
n-Lorem's Chief Operating Officer, Sarah Glass, Ph.D., is in purple in support of #EpilepsyAwarenessMonth ! Join in on spreading awareness by wearing purple. Epilepsy Foundation of America #nlorem #mynanorarestory #nanorare #supportnanorare #raredisease #nanorare disease
Bianca Zardetto from Marlen Lauffer & AnnemiekeAartsma-Rus team presenting a beautiful poster at the Cure CLCN4 conference about exciting reduction in time to make oligodendrocytes from patient fibroblasts that will be so helpful for trialing new ASO therapies for #nanorare conditions
